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Background: Coronary sinus lead placement for transvenous left ventricular (LV) pacing in resynchronization therapy (CRT) has a significant failure 
rate at implant and a considerable dislocation rate during follow-up. The aim of this prospective study was to assess the feasibility and the mid-term 
effects of a novel endocardial approach for LV lead implantation.
Methods: 14 end-stage heart failure patients (NYHA functional class III or IV; QRS ≥ 130 ms; LV ejection fraction (LVEF) ≤ 35% and LV end-
diastolic diameter (LVEDD) ≥ 60 mm) were included. In each procedure an active fixation lead was placed into the LV cavity using standard 
Seldinger technique through the LV apex. Using a “J” shape guide wire the tip of the lead was positioned and fixed into the basal-lateral segment of 
the LV. Follow up visits were scheduled at 3, 6, and 12 months and the following parameters were assessed: LVEF, LVEDD, LV end-systolic diameter 
(LVESD), NYHA class.
Results: There were no major complications related to the surgical intervention. During the follow up period (mean 15.9±4.52) 12 patients 
responded favorably to the treatment (85%). At one year follow up LVEF improved and LV diameters decreased significantly (LVEF 26.0±7.8% vs 
35.5±11.5%, p<0.01; LVEDD 73.5±10.5 mm vs 69.5±10.5 mm, p<0.01; LVESD 62.6±10.4 mm vs 55.5±13.0 mm, p<0.01). This was associated 
with a significant improvement of the NYHA class (3.5±0.4 vs 2.3±0.4, p< 0.01). Lead dislocation was detected in two patients, in whom lead 
repositioning could be performed without re-opening of the pleural cavity. One patient developed endocarditis. Transesophageal echocardiography 
and complete pacing system removal revealed right-sided vegetation attached to the shock coil of the right ventricular ICD lead.
Conclusions: Our data suggest that transapical endocardial CRT is a feasible alternative for patients in whom percutaneous delivery of the LV pacing 
lead fails. Our data suggest that the beneficial effects of endocardial CRT is sustained at one year follow up without increased complication rate.
